/
BSX
$46.23-$0.04 (-0.09%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$68.4B
1,486M shares
52-week range
$42.20 – $109.50
6% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Change+$0.12
Boston Scientific Corp.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
www.bostonscientific.com- Employees
- 59,000
- IPO / List date
- May 18, 1992
- HQ
- MARLBOROUGH, MA
Held by traders on TradeandTell
No one on the platform currently holds BSX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 3,152,005 | $197.8M |
| The Baupost Groupas of 2026-03-31 | 104,655 | $6.6M |
Recent trades on TradeandTell
No one on the platform has traded BSX yet.
